{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=0.004%25+Travoprost&page=2", "query": { "intervention": "0.004% Travoprost", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 28, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=0.004%25+Travoprost&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=0.004%25+Travoprost&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-07T11:23:47.424Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02419508", "title": "SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Open-Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension", "type": "DRUG" }, { "name": "Brinz/brim vehicle", "type": "DRUG" }, { "name": "Prostaglandin analogue", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 290, "start_date": "2015-08-07", "completion_date": "2018-02-27", "has_results": true, "last_update_posted_date": "2018-11-15", "last_synced_at": "2026-10-07T11:23:47.424Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02419508" }, { "nct_id": "NCT00051155", "title": "A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "Travoprost (0.004%)", "type": "DRUG" }, { "name": "Latanoprost (0.005%)/Timolol (0.5%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2001-01", "completion_date": "2004-07", "has_results": false, "last_update_posted_date": "2008-08-05", "last_synced_at": "2026-10-07T11:23:47.424Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00051155" }, { "nct_id": "NCT00799682", "title": "Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Dry Eye Disease" ], "interventions": [ { "name": "Xalatan", "type": "DRUG" }, { "name": "Travatan Z", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ophthalmic Consultants of Long Island", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 56, "start_date": "2008-10", "completion_date": "2011-02", "has_results": false, "last_update_posted_date": "2011-07-21", "last_synced_at": "2026-10-07T11:23:47.424Z", "location_count": 5, "location_summary": "East Meadow, New York • Lynbrook, New York • Rockville Centre, New York + 2 more", "locations": [ { "city": "East Meadow", "state": "New York" }, { "city": "Lynbrook", "state": "New York" }, { "city": "Rockville Centre", "state": "New York" }, { "city": "Stony Brook", "state": "New York" }, { "city": "Valley Stream", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00799682" }, { "nct_id": "NCT00051142", "title": "A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "Travoprost", "type": "DRUG" }, { "name": "Latanoprost", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2001-02", "completion_date": "2004-06", "has_results": false, "last_update_posted_date": "2008-08-05", "last_synced_at": "2026-10-07T11:23:47.424Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00051142" }, { "nct_id": "NCT00347802", "title": "Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma" ], "interventions": [ { "name": "Bimatoprost 0.03%, Travoprost 0.004%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Innovative Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2007-06-01", "last_synced_at": "2026-10-07T11:23:47.424Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00347802" }, { "nct_id": "NCT00465803", "title": "A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Open-angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Travoprost 0.004%/timolol 0.5% ophthalmic solution", "type": "DRUG" }, { "name": "Travoprost ophthalmic solution, 0.004%", "type": "DRUG" }, { "name": "Timolol maleate ophthalmic solution, 0.5%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 81, "start_date": "2007-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-07-24", "last_synced_at": "2026-10-07T11:23:47.424Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00465803" }, { "nct_id": "NCT01114893", "title": "Travoprost Five Day Posology Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Open-angle Glaucoma (OAG)", "Ocular Hypertension" ], "interventions": [ { "name": "Travoprost 0.004%", "type": "DRUG" }, { "name": "Travoprost Vehicle", "type": "DRUG" }, { "name": "Travoprost (Groups A, B and C)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2010-04", "completion_date": null, "has_results": true, "last_update_posted_date": "2011-06-23", "last_synced_at": "2026-10-07T11:23:47.424Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01114893" }, { "nct_id": "NCT00763061", "title": "Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma" ], "interventions": [ { "name": "Travoprost 0.004% Ophthalmic Solution (Travatan)", "type": "DRUG" }, { "name": "Timolol 0.5% Ophthalmic Solution (Timoptic)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 111, "start_date": "2006-05", "completion_date": "2008-04", "has_results": true, "last_update_posted_date": "2010-03-02", "last_synced_at": "2026-10-07T11:23:47.424Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00763061" }, { "nct_id": "NCT06152861", "title": "Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Open Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Travoprost Ophthalmic Topical Cream low-dose", "type": "DRUG" }, { "name": "Travoprost Ophthalmic Topical Cream mid-dose", "type": "DRUG" }, { "name": "Travoprost Ophthalmic Topical Cream high-dose", "type": "DRUG" }, { "name": "Timolol maleate ophthalmic solution, 0.5%", "type": "DRUG" }, { "name": "Travoprost Ophthalmic Solution, 0.004%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Glaukos Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2023-11-15", "completion_date": "2024-08", "has_results": false, "last_update_posted_date": "2023-12-06", "last_synced_at": "2026-10-07T11:23:47.424Z", "location_count": 1, "location_summary": "Newport Beach, California", "locations": [ { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06152861" }, { "nct_id": "NCT00716742", "title": "Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Open-Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "bimatoprost 0.03%, latanoprost 0.005%, and travoprost 0.004%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1099, "start_date": "2004-09", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2012-01-06", "last_synced_at": "2026-10-07T11:23:47.424Z", "location_count": 1, "location_summary": "Murfreesboro, Tennessee", "locations": [ { "city": "Murfreesboro", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00716742" } ] }